Aldeyra Therapeutics Aktie
1,49
EUR
±0,00
EUR
±0,00
%
1,71
USD
-0,04
USD
-2,01
%
Aldeyra Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Aldeyra Therapeutics Aktie Analyse
| 26.09.18 | Aldeyra Therapeutics Overweight | Cantor Fitzgerald | |
| 26.01.18 | Aldeyra Therapeutics Buy | Seaport Global Securities | |
| 26.09.16 | Aldeyra Therapeutics Buy | H.C. Wainwright & Co. | |
| 01.07.16 | Aldeyra Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 01.07.15 | Aldeyra Therapeutics Buy | Canaccord Adams | |
| 25.03.15 | Aldeyra Therapeutics Buy | Chardan Capital Markets | |
| 20.03.15 | Aldeyra Therapeutics Buy | H.C. Wainwright & Co. | |
| 18.11.14 | Aldeyra Therapeutics Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
Werbung
Werbung